# STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial

> **NCT06084000** · NA · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 2700 (estimated)

## Conditions studied

- Drug-coated Balloon
- Drug-eluting Stent
- De Novo Stenosis

## Interventions

- **DEVICE:** Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
- **DEVICE:** Drug-eluting stent

## Key facts

- **NCT ID:** NCT06084000
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-15
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 2700 (ESTIMATED)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084000, "STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06084000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*